Table 1 Preoperative characteristics
Group I (N = 10) | Group II (N = 27) | p value | |
|---|---|---|---|
Age (years) | 68.0 ± 15.0 | 62.8 ± 15.3 | 0.217 |
Female | 5 (50.0%) | 9 (33.3%) | 0.454 |
BSA (m 2 ) | 1.54 ± 0.29 | 1.57 ± 0.18 | 0.411 |
LVEF (%) | 50.5 ± 19.8 | 64.4 ± 12.0 | 0.046 |
PAP (mmHg) | 37.1 ± 13.7 | 42.9 ± 13.9 | 0.255 |
LVDd (mm) | 57.0 ± 8.7 | 48.2 ± 6.7 | 0.009 |
LVDs (mm) | 42.3 ± 15.2 | 30.6 ± 5.9 | 0.009 |
LAD (mm) | 46.5 ± 9.3 | 50.2 ± 11.9 | 0.339 |
MR (0–4) | 3.9 ± 0.2 | 3.1 ± 1.1 | 0.046 |
AF | 3 (30.0%) | 11 (40.7%) | 0.710 |
NYHA (1–4) | 2.6 ± 0.7 | 2.2 ± 1.0 | 0.228 |
Euro SCORE | 4.8 ± 2.0 | 3.8 ± 2.4 | 0.037 |
Prior cardiac surgery | |||
MVP | 5 (50.0%) | 9 (33.3%) | 0.454 |
CABG | 3 (30.0%) | 1 (3.7%) | 0.052 |
MVR | 0 (0%) | 5 (18.5%) | 0.295 |
AVR | 1 (10.0%) | 3 (11.1%) | 1.000 |
Redo MVR | 1 (10.0%) | 1 (3.7%) | 0.473 |
Congenital cardiac surgery | 0 (0%) | 4 (14.8%) | 0.557 |
Complex valve surgery | 0 (0%) | 3 (11.1%) | 0.548 |
Bentall procedure | 0 (0%) | 1 (3.7%) | 1.000 |